Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
33 Leser
Artikel bewerten:
(0)

Asia Cervical Cancer Test Market & Patients Report 2017 - Pap Smear, HPV DNA, VIA Test Market, Volume & Deaths 2008-2020 - Research and Markets

DUBLIN, Feb. 2, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Cervical Cancer Test Market & Patients (Pap Smear, HPV DNA, VIA) in Asia (Japan, Korea, Singapore, Malaysia, India, China, Thailand, Indonesia)" report to their offering.

Despite declining women population, Japan has highest market share in cervical cancer test market. Whereas Indonesia is dominating in cervical cancer testing population followed by China. Growing women population, rising sum of structured cervical cancer programs introduced by governments and international NGOs and inception of low cost VIA test are some of the major growth drivers for the growth of cervical cancer test market in the developing countries.

Cervical Cancer Test Market & Patients (Pap Smear, HPV DNA, VIA) in Asia (Japan, Korea, Singapore, Malaysia, India, China, Thailand, Indonesia) provides a comprehensive analysis of this market and future evolution over the next 5 years.

This 121 page report with 118 Figures and 4 Table provides a complete analysis of top 8 Countries Cervical Cancer Test Market & Population. All the 8 Asian countries in the report have been studied from 3 viewpoints.

Asia Cervical Cancer Test Market, Volume & Deaths:

- Cervical cancer Test Population (2008 - 2020)
- Pap smear test population (2008 - 2020)
- HPV DNA test population (2008 - 2020)
- VIA test Population (2008 - 2020)
- Cervical Cancer Mortality Population (2001 - 2011)
- Cervical Cancer Test Market (2008 - 2020)
- Pap smear test market (2008 - 2020)
- HPV DNA test market (2008 - 2020)
- VIA test market (2008 - 2020)

Key Topics Covered:

1. Executive Summary

2. Asia Cervical Cancer Test (Screening) Population & Forecast

3. Asia Cervical Cancer Test (Screening) Market & Forecast

4. Asia Cervical Cancer Test (Screening) Population Share & Forecast

5. Asia Cervical Cancer Test (Screening) Market Share & Forecast

6. Japan - Cervical Cancer Test Analysis

7. South Korea - Cervical Cancer Tests Analysis

8. Singapore - Cervical Cancer Tests Analysis

9. Malaysia - Cervical Cancer Test Analysis

10. India - Cervical Cancer Test Analysis

11. China - Cervical Cancer Test Analysis

12. Thailand - Cervical Cancer Test Analysis

13. Indonesia - Cervical Cancer Test Analysis

14. Cervical Cancer Test Market Growth Drivers

15. Challenges in Cervical Cancer Test Market

For more information about this report visit http://www.researchandmarkets.com/research/hzccsp/cervical_cancer

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.